Start Date
December 31, 2004
Primary Completion Date
March 31, 2006
Study Completion Date
March 31, 2006
Tedisamil sesquifumarate
Site 82, Tullahoma
Site 2, Buenos Aires
Site 3, Buenos Aires
Site 5, Munro
Site 4, San Miguel de Tucumán
Site 8, Brno
Site 11, Jindřichův Hradec
Site 9, Ostrava-Poruba
Site 10, Pilsen
Site 14, Prague
Site 6, Prague
Site 7, Prague
Site 12, Slaný
Site 13, Ústí nad Orlicí
Site 15, Bad Nauheim
Site 17, Göttingen
Site 16, Halle
Site 18, Haifa
Site 19, Jerusalem
Site 22, Jerusalem
Site 23, Jerusalem
Site 20, Tel Aviv
Site 21, Tel Aviv
Site 26, Bydgoszcz
Site 32, Bydgoszcz
Site 30, Lodz
Site 29, Lublin
Site 36, Lublin
Site 31, Medyczna
Site 33, Szczecin
Site 24, Warsaw
Site 25, Warsaw
Site 27, Warsaw
Site 28, Warsaw
Site 34, Wroclaw
Site 35, Wroclaw
Site 38, Brasov
Site 39, Bucharest
Site 40, Bucharest
Site 37, Tg. Mures
Site 41, Moscow
Site 42, Moscow
Site 43, Moscow
Site 44, Moscow
Site 45, Moscow
Site 46, Moscow
Site 47, Moscow
Site 48, Moscow
Site 49, Moscow
Site 51, Moscow
Site 50, Saint Petersburg
Site 52, Belgrade
Site 53, Belgrade
Site 54, Belgrade
Site 57, Belgrade
Site 58, Belgrade
Site 56, Niska Banja
Site 55, Sremska Kamenica
Site 60, Banská Bystrica
Site 64, Bratislava
Site 61, Košice
Site 62, Lučenec
Site 59, Nitra
Site 65, Nové Zámky
Site 63, Prešov
Site 66, Cape Town
Site 67, Cape Town
Site 68, Dnipro
Site 69, Dnipro
Site 71, Donetsk
Site 72, Donetsk
Site 75, Kharkiv
Site 70, Kiev
Site 73, Kiev
Site 76, Kiev
Site 77, Kiev
Site 74, Lviv
Site 80, Odesa
Site 79, Zaporizhya
Site 78, Zaporizhzhya
Site 81, London
Solvay Pharmaceuticals
INDUSTRY